Guided Therapeutics Signs China Distribution Deal

    Key Terms class ii medical devices regulatory A regulatory category for medical devices that pose moderate risk to patients and therefore require more than basic controls but less than the strictest oversight. Class II devices are subject to special controls such as performance standards, specific labeling, testing…

    Read More
    General Mills to sell Häagen-Dazs shops in China

      Vor Bio: China NMPA approves telitacicept for Sjögren’s

      Vor Bio (Nasdaq: VOR)/b) and partner RemeGen announced that China’s NMPA has approved for adult patients with Sjögren’s disease (SjD), the first and only approved SjD therapy in China. The decision is based on a Phase 3 trial showing statistically significant ESSDAI and clinically meaningful ESSPRI improvements, with a favorable…

      Read More